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2112Objective: Coronary-subclavian steal syndrome (CSSS) is a rare cause of myocardial ischemia subsequent to
stenosis or occlusion of the subclavian artery (SA) proximal to internal thoracic artery (ITA) coronary bypass.
Only single cases have been reported in published studies to date. We report a significant series of patients with
late CSSS treated through an endovascular approach.
Methods:We reviewed a series of consecutive patients treated for CSSS. The clinical, anatomic, and technical
characteristics of the procedures were considered. Follow-up was performed through clinical and laboratory
(electrocardiography, echocardiography, duplex ultrasonography) evaluations.
Results: From January 2005 to March 2013, 10 patients with CSSS were treated; 7 had stable and 3 unstable
angina. Of the 10 patients, 8 had left SA stenosis (6 ostial to the origin and 2 in the middle segment), 1 had
proximal occlusion of the left SA, and 1 had stenosis in the innominate artery (proximally to a right internal
thoracic artery). Arterial access was at the brachial artery through surgical exposure (n ¼ 6), or radial artery
percutaneously (n ¼ 3). In 1 case of proximal occlusion of the left SA, simultaneous femoral and percutaneous
radial access was necessary. Predilatation of the stenotic lesion was performed in 6. Balloon expandable stents
were used in 7 patients with proximal ostial stenosis or occlusion and self-expandable stents in 2 with nonostial
lesions. In 1 other patient with proximal heavy calcified stenosis, cutting-balloon predilatation was performed,
resulting in dissection of the SA and occlusion of the ITA graft; blood flowwas restored in the left upper arm and
myocardium by adjunctive dilatation of the SA and endovascular coronary revascularization. No patients devel-
oped angina during the follow-up period (15  7 months).
Conclusions: A tailored endovascular approach can be used to treat CSSS. However, the occurrence
of potentially lethal complications is possible and needs prompt correction. (J Thorac Cardiovasc Surg
2014;148:2112-6)Coronary-subclavian steal syndrome (CSSS) is a rare cause
of myocardial ischemia subsequent to occlusive disease of
the subclavian artery (SA) proximally to an internal
thoracic artery (ITA) coronary bypass.1 If SA occlusive
disease, possibly leading to CSSS, is detected before the
coronary bypass procedure, the surgical approach to
myocardial revascularization can be modified or the
stenosis corrected beforehand or simultaneously.2-4
However, postoperative CSSS will develop in about 1%
to 4% of patients who have undergone coronary artery
bypass grafting (CABG) with an ITA graft,2,5 with its late
incidence undefined in published studies. The onset of
CSSS some years after coronary revascularization has
been sporadically reported through single case reports.6-11
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The technique of choice is yet to be defined; however,
an endovascular approach could be advantageous in
terms of invasiveness. Surgical extra-anatomic bypass
(subclavian–subclavian or carotid–subclavian) can be a
valuable alternative.12,13
The aim of the present study was to review our
experience in the treatment of late CSSS.
METHODS
Study Design and CSSS Diagnosis
We retrospectively reviewed, from January 2005 to July 2013, the
experience of a vascular surgery center (S. Orsola-Malpighi, Bologna,
Italy) and cardiologic interventional center (Maria Cecilia Hospital,
Cotignola, Ravenna, Italy) in the treatment of late CSSS. All patients
gave their informed consent for the procedure. The study was performed
according to the rules of the ethical review boards of our institutions.
All patients who had undergone CABGwith an ITA graft and had clinical
symptoms of angina were evaluated by coronarography and supra-aortic
vessel angiography. Computed tomography angiographywas also performed
in some instances.Hemodynamic stenosis proximal to the ITAwas defined as
a trans-stenosis pressure reduction of 30mmHg.3,12,13 The indication to treat
the stenosis was the simultaneous presence of symptoms of myocardial
ischemia and SA hemodynamic stenosis proximal to the ITA.12
Patients
The patients’ clinical characteristics, interval from CABG to the new
angina symptoms, type of myocardial symptoms, technical aspects of thegery c November 2014
TABLE 1. Patient characteristics
Variable n (%)
Clinical characteristics
Male gender 7 (70)








Double antiplatelet agents 10 (100)
b-blockers 8 (80)
Interval from CABG (y) 9  8.4
Type of symptoms
Stable angina 7 (70)
Unstable angina 3 (30)
Data presented as n (%) or mean  standard deviation. COPD, Chronic obstructive
pulmonary disease; CRF, chronic renal failure; CABG, coronary artery bypass
grafting.








Ostium of left SA 4 (57)
Middle segment of SA 2 (29)
Innominate artery 1 (14)
Obstruction location
Ostium of left SA 3 (100)
SA, Subclavian artery.
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CSSS ¼ coronary-subclavian steal syndrome
ITA ¼ internal thoracic artery
SA ¼ subclavian artery
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Drevascularization procedure, and perioperative (30-day) outcomes were
entered into a dedicated database. The stenosis was categorized as ostial
(in the SA or innominate artery) or located in the middle segment of the
vessel proximal to the ITA.
The clinical characteristics included the following: age, gender,
hypertension (presence of systolic blood pressure>140 and/or diastolic
blood pressure >90 mm Hg or specific therapy), dyslipidemia
(total cholesterol>200 mg/dL or low-density lipoprotein>120 mg/dL or
specific therapy), diabetes mellitus (prediagnosed in therapy with oral hy-
poglycemic drugs or with insulin), current smoking, chronic obstructive
pulmonary disease (defined as chronic bronchitis or emphysema),
and chronic renal failure (glomerular filtration rate <60 mL/min).
Ongoing therapy with antiplatelet drugs (single or double), b-blockers,
anticoagulant agents, and statins was also considered.
The clinical and electrocardiographic findings of new myocardial
ischemic symptoms and recurrence of proximal SA disease by duplex
ultrasound examination were considered in the follow-up period.
Revascularization Procedures
All procedures were performed with the patients under local anesthesia
and systemic heparinization. The access site varied according to the
location and type of occlusive disease (stenosis vs occlusion). In the
vascular surgery department, surgical exposure of the brachial artery was
the approach of choice. In the interventional coronary unit, percutaneous
access was the approach of choice. Predilatation was performed when
necessary to cross the stenosis with the stent. Balloon expandable stents
were used for the ostial lesions and self-expandable for lesions located in
the middle segment of the vessels.
The perioperative results included ‘‘technical success,’’ defined as
treatment resulting in<30% residual stenosis, myocardial or neurologic
ischemic events, and access complications (hematoma with the necessity
for blood transfusion or surgical revision).
RESULTS
General Characteristics
From January 2005 to March 2013, 10 patients with CSSS
were treated: 6 in the vascular surgery department and 4 in the
cardiologic interventional unit. The mean interval from
CABG to the development of angina symptoms was 9.0 
8.4 years. The patients’ clinical characteristics are reported
in Table 1. Because all patients were referred from other insti-
tutions, we could not assess the incidence of CSSS. Of the 10
patients, 7 had an ostial SA lesion (4 stenosis and 3 occlusion),
2 had stenosis of the middle segment of the left SA, and 1 had
stenosis in the middle segment of the innominate artery
proximally to a right ITA CABG (Table 2). All patients with
unstable angina had total ostial SA occlusion and vice versa.
Vascular Access
Surgical left brachial artery exposure. In all 6 patients
treated in the vascular surgery department, surgicalThe Journal of Thoracic and Carexposure of the left brachial artery was performed. This
approach allows one to cross the lesion with the angio-
graphic catheter in the presence of stenosis and to have
sufficient ‘‘pushability’’ through a 6F, 10-cm, introducer
(Cordis, Waterloo, Belgium) in the presence of occlusion
to cross it with the guidewire (Terumo, Tokyo, Japan).
Percutaneous radial access. Percutaneous radial access
was used in 3 patients treated in the cardiologic interven-
tional unit through a 6F sheath (Cordis,Waterloo, Belgium),
2 with stenosis of the middle segment of the SA and 1 of the
innominate artery.
Simultaneous percutaneous femoral and radial access.
In the case of ostial occlusion of the left SA, simultaneous
right femoral (7F sheath Cordis, Waterloo, Belgium) and
left radial (6F sheath, Cordis) percutaneous access was
performed.
Stenosis Crossing, Predilatation, and Stenting
The stenoses were crossed by a 0.035-in. floppy wire
(Terumo, Tokyo, Japan) in 4 patients; in 3 patients withdiovascular Surgery c Volume 148, Number 5 2113
FIGURE 1. Focal occlusion of middle segment of subclavian artery. A, Preoperative angiographic view; B, view of predilatation; C-E, stent deployment;
and F, final angiographic view.
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Dsubocclusive stenosis and 3 with occlusion, a stiff 0.018-in.
(V18, Boston Scientific, Natick, Mass) wire was used
(Figure 1). Predilatation was performed in 6 cases with a
balloon catheter, ranging from 2.5 3 4.0 mm to 5.0 3 4.0
mm. In 1 patient with a heavily calcified ostial SA stenosis,
dilatation with cutting balloon (4.0 3 15 mm, Flextome
Cutting Balloon, Natick, Mass) was performed and was
complicated by SA spiral dissection and ITA occlusion
(Figure 2). The SA dissection was resolved with prolonged
ballooning of the SA, allowing reperfusion of the upper left
arm. Also, an endovascular coronary revascularization was
performed to maximize the myocardial perfusion.
The stent type was chosen according to the type of
stenosis. A balloon expandable stent was placed in the 3
ostial stenoses and in the 3 ostial occlusions (Table 3) to
achieve accurate dilatation and avoid protrusion of the stent
in the aortic arch. A self-expandable stent was placed in
the 2 stenosis of the middle segment of the SA and in the
stenosis of the innominate artery.Outcome and Follow-up
Technical success was achieved in 9 patients. The 1 pa-
tient with dissection of the SA did not have any myocardial2114 The Journal of Thoracic and Cardiovascular Surcomplications; however, the ITA graft was lost, and the case
should be considered a technical failure. No myocardial or
neurologic complications developed. The patient with SA
dissection and ITA occlusion had no myocardial sequelae.
One patient with surgical left brachial artery access devel-
oped a hematoma that required surgical revision on postop-
erative day 1. At a mean follow-up of 14.4 8.7 months, all
patients were asymptomatic for new angina symptoms, with
no signs of restenosis at duplex ultrasonography, either
direct (in the cases of stenting of the middle SA) or indirect
(through measurement of the flow distal to an ostial lesion).DISCUSSION
The number of patients with late CSSS reported in the
present study is the most significant published to date.
However, the frequency of CSSS could not be assessed,
because all the patients were referred from other hospitals.
Thus, we have combined the patients treated in 2 units
(vascular surgery unit and interventional cardiologic unit),
describing 2 different approaches to the same problem. In
patients treated by the vascular surgeons, a minimal
brachial artery surgical exposure was chosen for access to
have greater ‘‘pushability’’ of the wire for crossing thegery c November 2014
FIGURE 2. Treated subclavian stenosis complicated by arterial dissection. A, Preoperative angiographic view; B, predilatation with cutting balloon; C and
D, subclavian artery dissection; E and F, subclavian artery dilatation, resolution of the dissection, and occlusion of the internal thoracic artery; and G-I,
coronary revascularization.
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Dlesion. Surgical exposure of the vessel is easily performed
by experienced vascular surgeons, with minimal potential
for complications. The radial approach could be advanta-
geous for skilled cardiologists, but when inadequate, the
percutaneous upper arm approach might be troublesome
in some patients.
Balloon expandable stents were used in the presence of
an ostial lesion; in those cases, high deployment precision
is necessary to avoid inadvertent protrusion of the stent
in the aortic arch or distal slipping. However, a self-
expandable stent was chosen for long stenoses of the medial
vessels segments, given the minor radial force necessary
and the low risk of misplacement. Balloon-expandable
stents were generally chosen 1 or 2 mm smaller than the
native arterial diameter, in consideration of the severe
stenosis present and the stent overdilatation caused by the
balloon. In contrast, self-expandable stents were 1 to 2The Journal of Thoracic and Carmm larger than the artery diameter because of their greater
conformability.
Despite the overall satisfactory results obtained in the
present series, a major complication occurred when the pre-
dilatation with a cutting balloon led to a dissection of the SA
and occlusion of the ITA. Although the complication was
successfully resolved with prolonged SA ballooning and
new coronary endovascular revascularization, with no
myocardial or neurological sequelae, it is a potentially
lethal event. Thus, its occurrence must be considered
when submitting patients with CSSS to endovascular
treatment. The cutting ballooning should therefore be
used cautiously in SAs with heavy calcified stenoses.
Only case reports have been published about late CSSS
and its treatment. Most have referred to endovascular
approaches, with good results in the short to medium
term. In their report, Song and colleagues14 compareddiovascular Surgery c Volume 148, Number 5 2115
TABLE 3. Material characteristics
Characteristic Lesion anatomy n (%)
Stent type
Self expandable 3 (30)
Stenosis of innominate artery 1
Stenosis of middle segment of SA 2
Balloon expandable 6 (60)




Percutaneous radial access 3 (30)
Stenosis of innominate artery 1
Stenosis of middle segment of SA 2
Percutaneous femoral access 1 (10)
Ostial occlusion 1
Surgical brachial access 6 (60)
Ostial stenosis of SA 4
Ostial occlusion of SA 2
7F
Percutaneous femoral access 1 (10)
Ostial occlusion 1
Wire type
Floppy, 0.035 in. 4 (40)
Nonsubocclusive stenosis 4






SA, Subclavian artery. *Balloon diameter, 2.53 40 to 5.03 40mm. yCutting balloon,
4.0 3 15 mm.
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Dendovascular and surgical revascularization for subclavian
steal syndrome in patients without ITA CABG. Both
endovascular stenting (n ¼ 148) and extrathoracic surgical
bypass (n¼ 104) were shown to be safe and effective in the
short to medium term. However, surgical bypass has
been more durable, with a 5-year primary patency for
endovascular stenting versus extrathoracic surgical bypass
of 67% versus 95% and a cumulative secondary 10-year
patency of 64% versus 94%, respectively.
The surgical approach can be an alternative to endovas-
cular treatment; however, no studies have compared these
2 techniques for CSSS. Surgical subclavian revasculariza-
tion can be performed using several methods, such as
subclavian to subclavian bypass6 or carotid to subclavian
bypass. When stenosis or occlusion of the left SA has
been identified before CABG, the surgical approach of the2116 The Journal of Thoracic and Cardiovascular Surlatter can be modified with the performance of extrathoracic
bypass grafts or anastomosis of the saphenous vein graft
directly to the aorta, using the ITA as a bypass graft from
the aorta to the subclavian vein.15
CONCLUSIONS
CSSS is a severe pathologic entity associated with
extensive atherosclerotic involvement.9 To restore direct
flow in the SA is the key point to preserving the coronary
perfusion provided by the ITA, and the endovascular
approach is effective, durable, and generally safe.
However, the risk of severe complications should not be
underestimated, particularly in the case of calcific lesions.
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